A couple of things I did notice about today’s notice.
1) Announcement dated 8 May19 - “Patient treatment 75% complete. Recruitment expected to be complete by Q2, CY2019
Today’s announcement - “Patient treatment 75% complete. Recruitment expected to be complete by Q4, CY2019.
Haven’t recruited anybody for this trial in nearly 6 months!!! Nobody is getting injured, which is a good thing, or nobody knows about the trial, which is a bad thing.
2) 86% of patients who required prescription medication for pain relief were able to significantly reduce, or cease their use of said medication. Good for the patient, on several fronts, including reducing the risk of becoming addicted to opiod-based medications, and good for the federal budget, less money spent on said medications. Helps sell the product.
Ann: CelGro Nerve Regeneration Results in Quadriplegic Patients, page-120
Add OCC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
51.5¢ |
Change
0.035(7.29%) |
Mkt cap ! $107.9M | |||
| Open | High | Low | Value | Volume |
| 50.5¢ | 53.0¢ | 50.0¢ | $1.329M | 2.593M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 28629 | 51.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 51.5¢ | 11758 | 1 |
View Market Depth
| Last trade - 16.10pm 08/10/2024 (20 minute delay) ? |
| OCC (ASX) Chart |